Anticancer agent 265

Anticancer agent 265 (compound 1) is an anticancer compound. Anticancer agent 265 exhibits in vitro anticancer activity against three human bone cancer lines, U2OS, Saos-2, and GC9811, with IC50 values of 13.1, 11.7, and 14.6 μM, respectively[1].

Product Specifications

CAS Number

[184177-83-1]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Drug Derivative

Related Pathways

Others

Field of Research

Cancer

Purity

99.74

Smiles

O=C1N(C2=CC=C(N3CCN(C4=CC=C(O)C=C4)CC3)C=C2)C=NN1[C@@H](CC)[C@@H](OCC5=CC=CC=C5)C

Molecular Formula

C30H35N5O3

Molecular Weight

513.63

Precautions

H302, H315, H319, H335

References & Citations

[1]G Lv, et al. Synthesis, crystal structure, anti-bone cancer activity and molecular docking investigations of the heterocyclic compound 1- ((2S, 3S) -2- (benzyloxy) pentan-3-yl) -4- (4- (4- (4-hydroxyphenyl) piperazin-1-yl) phenyl) -1H-1, 2, 4-triazol-5 (4H) -one. Journal of Structural Chemistry 60.7 (2019) : 1173-1179.